Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821736) titled 'Impact of Leukoreduction Timing on Plasma Citrullinated Histone H3 (H3cit) Dynamics and Red Blood Cell Storage Lesions' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Assiut University

Condition: Healthy Donors

Intervention: Other: H3Cit

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Target Sample Size: 60

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07821736

Published by ...